Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.
about
Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Characterisation of the clinic ...... est T cell-targeted therapies.
@ast
Characterisation of the clinic ...... est T cell-targeted therapies.
@en
type
label
Characterisation of the clinic ...... est T cell-targeted therapies.
@ast
Characterisation of the clinic ...... est T cell-targeted therapies.
@en
prefLabel
Characterisation of the clinic ...... est T cell-targeted therapies.
@ast
Characterisation of the clinic ...... est T cell-targeted therapies.
@en
P2093
P2860
P1476
Characterisation of the clinic ...... est T cell-targeted therapies.
@en
P2093
Alexandra Belson
Bill Davis
Deborah Clark
Disala Fernando
John Stone
Kelly Hardes
Nicola Scott
Sara Brett
Simon McHugh
Tim Schmidt
P2860
P2888
P304
P356
10.1007/S00011-016-0923-4
P577
2016-03-11T00:00:00Z